Metronomic oral doxorubicin in combination of Chk1 inhibitor MK-8776 for p53-deficient breast cancer treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Metronomic oral doxorubicin in combination of Chk1 inhibitor MK-8776 for p53-deficient breast cancer treatment

Published:2018-11 Issue: Volume:182 Page:35-43
ISSN:0142-9612
Container-title:Biomaterials
language:en
Short-container-title:Biomaterials

Author:

Chung Seung Woo,Kim Gui Chul,Kweon Seho,Lee Hanul,Choi Jeong Uk,Mahmud Foyez,Chang Hyo Won,Kim Ji Won,Son Woo-Chan,Kim Sang Yoon,Byun Youngro

Funder

National Research Foundation of Korea

Ministry of Science, ICT & Future Planning of the Korea government

Publisher

Elsevier BV

Subject

Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering

Reference45 articles.

1. Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice;Hanahan;J. Clin. Invest.,2000

2. Repopulation of cancer cells during therapy: an important cause of treatment failure;Kim;Nat. Rev. Canc.,2005

3. Metronomics: towards personalized chemotherapy?;Andre;Nat. Rev. Clin. Oncol.,2014

4. Metronomics in the neoadjuvant and adjuvant treatment of breast cancer;Munzone;Canc. Lett.,2017

5. Metronomic chemotherapy for advanced breast cancer patients;Cazzaniga;Canc. Lett.,2017

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive review on doxorubicin: mechanisms, toxicity, clinical trials, combination therapies and nanoformulations in breast cancer;Drug Delivery and Translational Research;2024-06-17

2. Programmable intratumoral drug delivery to breast cancer using wireless bioelectronic device with electrochemical actuation;Expert Opinion on Drug Delivery;2024-02-28

3. Harnessing machine learning to find synergistic combinations for FDA-approved cancer drugs;Scientific Reports;2024-01-29

4. Mathematical modelling of microneedle-mediated transdermal delivery of drug nanocarriers into skin tissue and circulatory system;Journal of Controlled Release;2023-08

5. Computational simulations of tumor growth and treatment response: Benefits of high-frequency, low-dose drug regimens and concurrent vascular normalization;PLOS Computational Biology;2023-06-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3